Sorafenib as Monotherapy or in Association With Cytarabine and Clofarabine for the Treatment of Relapsed/Refractory FLT3 ITD-Positive Advanced Acute Myeloid Leukemia
Clinical Lymphoma, Myeloma and Leukemia- United States
doi 10.1016/j.clml.2013.08.005
Full Text
Abstract
Available in
Date
February 1, 2014
Authors
Publisher
Elsevier BV